Morning Overview on MSN
A new shot eased arthritic knee pain for years without replacement surgery
Millions of people with knee osteoarthritis live with daily pain and stiffness that erode their ability to walk, climb stairs ...
New minimally invasive treatment may help delay knee replacement surgery for osteoarthritis patients
A new minimally invasive procedure may reduce knee pain, improve mobility, and help some people with osteoarthritis postpone or avoid knee replacement surgery.
For many people with knee osteoarthritis, the hardest part is not getting a diagnosis. It is living in the awkward middle, ...
Scientists regrew knee cartilage by blocking an aging protein, opening a promising path for future osteoarthritis treatments.
Add Yahoo as a preferred source to see more of our stories on Google. Physiotherapist examining patient, illustration (AMR BO SHANAB/SCIENCE PHOTO LIBRARY via Getty Images) A knee brace appears to be ...
You never turn down an opportunity to play hide-and-seek with your granddaughter, and when a friend calls in absolute need of your signature dessert, you head straight to the kitchen, standing on your ...
New organ-on-a-chip model of human synovium could accelerate development of treatments for arthritis
The synovium is a membrane-like structure that lines the knee joint and helps to keep the joint happy and healthy, mainly by producing and maintaining synovial fluid. Inflammation of this tissue is ...
Topical NSAIDs, such as Voltaren Gel 1% (diclofenac sodium topical gel), have been shown to be effective in treating arthritic pain and cause fewer adverse effects than do oral NSAIDS. 18 Voltaren Gel ...
GREEN BAY, Wis. (WBAY) - The Arthritis Foundation says there are several types of arthritis that cause knee pain, including osteoarthritis, rheumatoid arthritis and gout. The CDC says the most common ...
A common diabetes drug can reduce the pain of people with knee osteoarthritis and overweight or obesity, possibly delaying the need for knee replacements, Monash University-led research has found.
Clinical Trials Arena on MSN
Kolon TissueGene’s stock drops on Phase III knee osteoarthritis trial failure
Kolon TissueGene’s stock dropped nearly 30% after the Phase III knee osteoarthritis trial failure.
Septic arthritis of the knee involves a sudden, severe infection in one or both knee joints. Without treatment, it can impair mobility, lead to permanent damage, or even be fatal. Septic arthritis is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results